Management of blood glucose in patients with stroke.
نویسندگان
چکیده
Stroke is a leading cause of death worldwide and the most common cause of long-term disability amongst adults, more particularly in patients with diabetes mellitus and arterial hypertension. Increasing evidence suggests that disordered physiological variables following acute ischaemic stroke, especially hyperglycaemia, adversely affect outcomes. Post-stroke hyperglycaemia is common (up to 50% of patients) and may be rather prolonged, regardless of diabetes status. A substantial body of evidence has demonstrated that hyperglycaemia has a deleterious effect upon clinical and morphological stroke outcomes. Therefore, hyperglycaemia represents an attractive physiological target for acute stroke therapies. However, whether intensive glycaemic manipulation positively influences the fate of ischaemic tissue remains unknown. One major adverse event of management of hyperglycaemia with insulin (either glucose-potassium-insulin infusions or intensive insulin therapy) is the occurrence of hypoglycaemia, which can also induce cerebral damage. Novel insights into post-stroke hyperglycaemia management have been derived from continuous glucose monitoring systems (CGMS). This article aims: 1) to describe the adverse effects of hyperglycaemia following acute ischaemic stroke and the risk associated with iatrogenic hypoglycaemia; 2) to summarise the evidence from current glucose-lowering treatment trials; and 3) to show the usefulness of CGMS in both non-diabetic and diabetic patients with acute stroke.
منابع مشابه
Outcome of patients with stroke admitted in stroke care unit and Neurologic
Introduction: Admission of patients with severe National Institutes of health stroke scale (NIHSS Score>16) or moderate (NIHSS 8 through 16) acute stroks is different. Taking care of stroke patients admitted in stroke unit care (SCU) is costly. In comparison with admission in general neurology ward, we assessed the outcome of such patients based on stroke care unit (SCU) versus general neurol...
متن کاملEpidemiologic Study of the Main Risk Factors for one Year Ischemic Stroke and Surivial in Patients Admitted to the Neurology Department of Ghayim Hospital in Mashhad, Iran, 2015
Introduction: Stroke is the third most common cause of death in developed countries and is the most common neurological disabling disease. Today, several risk factors are known for stroke including lifestyle and risk factors such as hypertension and diabetes which differ in cultures and countries. The aim of this study was to determine the frequency of ischemic stroke in patients admitted to th...
متن کاملVery low HbA1C, is it a problem?
Dear Editor An important problem to manage diabetes mellitus is controlling the patients` blood glucose. Fluctuation of blood glucose results in molecular biochemistry change and can result in unwanted diabetic complications (1). In clinical practice, hemoglobin A1C (HbA1C) is a common useful laboratory test to follow-up patients with diabetes (2). Sometimes, an unexpecte...
متن کاملConsequences of Intracranial Hemorrhage and Its Effective Factors
Background and purpose: Stroke is the third leading cause of death and the most common debilitating neurological disease. Intracranial Hemorrhage (ICH) is the second most prevalent form of stroke after ischemia. The aim of this study was to investigate the consequences of ICH and its effective factors. Materials and methods: In this prospective cross-sectional study, 288 patients with non-tra...
متن کاملBLOOD PRESSURE COMPONENTS AS PREDICTORS OF STROKE MORTALITY IN WEST SCOTLAND
The relative importance of systolic (SBP) versus diastolic blood pressure (DBP) and other combinations of SBP and DBP in the prediction of stroke have been re-examined in a long term cohort study of 10,541 men and women aged 45-64 in West Scotland. During a mean follow-up of 11.6 years 1, 616 deaths occurred, among which 160 (9.9% 80 male, 80 female) were due to stroke. In a multiple logi...
متن کاملP188: The Role of Cryotherapy in Progression of Brain Stroke
Stroke is a leading cause of mortality and morbidity in developed countries and has increased incidence due to progression of average population age. Pharmalogical and mechanical reperfusion therapy, as primary therapeutic approaches, are only applicable to less than 10% of patients with a 50-70% efficacy. but about 90%of patients are severe restricted to these treatments. Glutamate excitotoxic...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Diabetes & metabolism
دوره 36 Suppl 3 شماره
صفحات -
تاریخ انتشار 2010